학술논문
Enasidenib (ENA) Monotherapy with Addition of Azacitidine in Non-Responders Is Effective in Older Patients with Newly Diagnosed IDH2 Mutated Acute Myeloid Leukemia (AML): A Completed Phase 2/1b Sub-Study of the Beat AML Master Trial
Document Type
Abstract
Author
Stein, Eytan M.; Huang, Ying ; Borate, Uma; Baer, Maria R.; Stock, Wendy; Kovacsovics, Tibor; Blum, William; Schiller, Gary J.; Olin, Rebecca L.; Foran, James M.; Litzow, Mark; Lin, Tara; Patel, Prapti A.; Foster, Matthew C; Boyiadzis, Michael; Collins, Robert H.; Vergilio, Jo-Anne ; Heerema, Nyla A; Rosenberg, Leonard ; Yocum, Ashley Owen ; Chen, Timothy ; Druggan, Franchesca ; Marcus, Sonja ; Stefanos, Mona ; Chervin, Jordan ; Shoben, Abigail ; Druker, Brian J.; Burd, Amy; Byrd, John C.; Levine, Ross L.; Mims, Alice S.
Source
In Blood 5 November 2020 136 Supplement 1:27-30
Subject
Language
ISSN
0006-4971